Zobrazeno 1 - 10
of 10
pro vyhledávání: '"L Jiménez Guerrero"'
Autor:
I Castañeda Macias, S Sandoval Fernandez del Castillo, Alvarado Fernández, M Murillo Izquierdo, L Jiménez Guerrero
Publikováno v:
Drug information and pharmacotherapy.
Background Canakinumab is a IgG1 anti-interleukin-1β monoclonal antibody indicated in the treatment of Muckle–Wells syndrome (MWS). It is an autosomal dominant congenital disease that is considered a rare disease. Hives, joint pains, conjunctiviti
Autor:
I Castañeda Macias, M Vazquez Real, S Sandoval Fernandez del Castillo, M Murillo Izquierdo, L Jiménez Guerrero
Publikováno v:
General management.
Background We describe a 47-year-old women diagnosed with C3 category HIV infection in 1996. After other drug combinations, she started on LPV/r (a protease inhibitor (PI)) in 2007 and in 2013 she had a DDD pacemaker implanted. Purpose To explore whe
Autor:
C Donoso Rengifo, L Jiménez Guerrero, S Sandoval Fernandez del Castillo, M Nuñez Nuñez, I Castañeda Macias, M Murillo Izquierdo
Publikováno v:
Drug information and pharmacotherapy.
Background The δ-9-tetrahydrocannabinol-cannabidiol (THC-CBD) oromucosal spray (Sativex) is a standardised cannabinoid based medicine for add on treatment of resistant multiple sclerosis (MS) induced spasticity. Purpose To evaluate the use of oromuc
Autor:
L Jiménez Guerrero, S Santana Martínez, E Romero Carreño, C Donoso Rengifo, Alvarado Fernández, M Vazquez Real, JA Marcos Rodríguez
Publikováno v:
European Journal of Hospital Pharmacy. 23:A239.1-A239
Background Chemotherapy prescriptions validation by the oncology pharmacist often require interventions to optimise some aspects of the treatment, usually related to the safety and effectiveness of antineoplastic agents. Purpose Our pharmacy departme
Autor:
F Oliva-Monpean, L Jiménez-Guerrero, M Beltrán-García, JC Gómez Rosado, Guerrero-Aznar, M Murillo-Izquierdo
Publikováno v:
European Journal of Hospital Pharmacy. 23:A23.3-A24
Background Research for an effective method of improving quality of home medication reconciliation (HRM) within the surgery unit. Purpose Validate some indicators for monitoring interventions to improve the quality of HRM on admission to the surgery
Autor:
Donoso Rengifo, L Jiménez Guerrero, Alvarado Fernández, M Vázquez-Real, E Romero Carreño, I Castañeda Macias, S Santana Martínez
Publikováno v:
European Journal of Hospital Pharmacy. 22:A159.2-A160
Background Benzodiazepines (BZD) have to be reconciled within 24 h of admission to avoid withdrawal symptoms. On the other hand, it’s important to check the discharge report to avoid treatment discrepancies. Purpose To find out the accuracy of BZD
Autor:
Sara Santana, L Jiménez Guerrero, Alvarado Fernández, M Moya-Martin, MC Donoso Rengifo, M Vázquez-Real
Publikováno v:
European Journal of Hospital Pharmacy. 22:A178.2-A178
Background The cytostatic unit is a critical area in a hospital, therefore drug-related mistakes should be analysed in order to increase safety and effectiveness in patients treated with chemotherapy. Purpose To evaluate drug-related mistakes during
DI-081 Oral chemotherapy: incidence and description of potential interactions between drugs and food
Autor:
L Jiménez Guerrero, S Santana Martínez, JA Marcos Rodríguez, I Castañeda Macias, Alvarado Fernández, C Donoso Rengifo
Publikováno v:
European Journal of Hospital Pharmacy. 22:A106.1-A106
Background Oral chemotherapy is increasingly used in Oncology. It has important advantages, such as patient comfort, but it also brings new challenges which did not exist with the intravenous treatment. Some of these drugs have interactions with food
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.